DINA JACOBS: Open Payments
NPI 1972355469 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,653 in 143 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $835 · 2025 $2,653
Food & beverage: $2,653
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $428 |
| ABBVIE INC. | 28 | $353 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $209 |
| Kowa Pharmaceuticals America, Inc. | 15 | $208 |
| Novo Nordisk Inc | 12 | $199 |
| PFIZER INC. | 7 | $180 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $157 |
| Amgen Inc. | 11 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $129 |
| Phathom Pharmaceuticals, Inc. | 5 | $83 |
Products named: Kerendia, ZORYVE, VRAYLAR, BREZTRI, AIRSUPRA, XIFAXAN, CAPLYTA, ZAVZPRET.
Industry payments across NC — which companies pay providers there.
